A coroner has urged a review following the death of a young City finance worker of heart issues just days after his ADHD medication dosage was increased.
Coroner Sarah Bourke has called on the Government to launch an inquiry into Elvanse, which she described as 'increasingly being prescribed in the NHS'.
The new warning over the ADHD medication comes following the death of banker and musician Jacob Wooderson.
The 28-year-old collapsed and died at his London home having recently started taking Elvanse, the brand name for Lisdexamfetamine.
The financial analyst, who was educated at one of the UK's oldest private schools, had been diagnosed with ADHD six months before his death in August last year.
